Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Rapaport

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Blood|November 1, 1981
Heterogeneity in human prothrombin: analysis of causeS P Bajaj, S I Rapaport, C Prodonos, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 14, 1997
A Protac-based screening test for activated protein C-resistant factor Va and other defects of the protein C anticoagulant pathwayP S Gable, D T Le, W McGehee, et al.
Blood|June 1, 1985
Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and managementS P Bajaj, S I Rapaport, S Barclay, et al.
Blood|July 1, 1985
Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma componentN L Sanders, S P Bajaj, A Zivelin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 1997
The effect of immunodepletion of antithrombin III on the response of rabbits to Russell's viper venom-induced activation of factor XS I Rapaport, T Toneff, A Rimon, et al.
Thrombosis Research|July 15, 1990
Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibodyR A Fleck, L V Rao, S I Rapaport, et al.
Blood|July 1, 1971
Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiencyS H Goodnight, D I Feinstein, B Osterud, et al.
Thrombosis and Haemostasis|October 31, 1977
Platelet aggregate ratios--standardization of technique and test results in patients with myocardial ischemia and patients with cerebrovascular diseaseJ A Prazich, S I Rapaport, J R Samples, et al.
The Journal of Clinical Investigation|August 1, 1970
Factor V anticoagulants: clinical, biochemical, and immunological observationsD I Feinstein, S I Rapaport, W G McGehee, et al.
Thrombosis Research|October 1, 1987
Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor)B J Warn-Cramer, S L Maki, A Zivelin, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Blood|November 1, 1981
Heterogeneity in human prothrombin: analysis of causeS P Bajaj, S I Rapaport, C Prodonos, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 14, 1997
A Protac-based screening test for activated protein C-resistant factor Va and other defects of the protein C anticoagulant pathwayP S Gable, D T Le, W McGehee, et al.
Blood|June 1, 1985
Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and managementS P Bajaj, S I Rapaport, S Barclay, et al.
Blood|July 1, 1985
Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma componentN L Sanders, S P Bajaj, A Zivelin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 1997
The effect of immunodepletion of antithrombin III on the response of rabbits to Russell's viper venom-induced activation of factor XS I Rapaport, T Toneff, A Rimon, et al.
Thrombosis Research|July 15, 1990
Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibodyR A Fleck, L V Rao, S I Rapaport, et al.
Blood|July 1, 1971
Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiencyS H Goodnight, D I Feinstein, B Osterud, et al.
Thrombosis and Haemostasis|October 31, 1977
Platelet aggregate ratios--standardization of technique and test results in patients with myocardial ischemia and patients with cerebrovascular diseaseJ A Prazich, S I Rapaport, J R Samples, et al.
The Journal of Clinical Investigation|August 1, 1970
Factor V anticoagulants: clinical, biochemical, and immunological observationsD I Feinstein, S I Rapaport, W G McGehee, et al.
Thrombosis Research|October 1, 1987
Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor)B J Warn-Cramer, S L Maki, A Zivelin, et al.
Pageof 16